8,029 companies listed on NYSE, Nasdaq and the OTC markets. Financials come straight from their SEC filings.
Prices as of the close on Oct 19, 2026
How Healthcare stocks on Nasdaq moved on Oct 19, 2026
873 companies
| Market cap |
|---|
| Revenue |
|---|
| Net margin |
|---|
| P/E |
|---|
| 1 | oncBeOne Medicines | $370.17 | +0.30% | +21.84% | +16.99% | $547.16B | $6.13B | 10.7% | 834.5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 | amgnAmgen | $424.94 | −1.75% | +29.83% | +42.21% | $229.74B | $38.10B | 23.0% | 26.3 | |
| 3 | $153.07 | −2.00% | +24.71% | +24.64% | $189.80B | $30.46B | −10.6% | – | ||
| 4 | $433.18 | +1.52% | −23.52% | −2.90% | $153.03B | $11.03B | 28.4% | 48.8 | ||
| 5 | $501.95 | +0.44% | +10.72% | +20.43% | $127.22B | $12.59B | 35.0% | 28.9 | ||
| 6 | $226.89 | +4.07% | +669.4% | +772.3% | $90.58B | $2.23B | −141.4% | – | ||
| 7 | $782.04 | −1.10% | +1.32% | +35.29% | $80.51B | $15.53B | 27.9% | 18.6 | ||
| 8 | $399.42 | +1.52% | +74.35% | +119.8% | $57.57B | $2.71B | −7.1% | – | ||
| 9 | mdlnMedline | $35.19 | −2.14% | −16.21% | – | $46.26B | – | – | – | |
| 10 | $555.80 | −0.81% | −17.85% | −12.53% | $43.79B | $4.55B | 25.0% | 38.4 | ||
| 11 | ilmnIllumina | $262.66 | +0.05% | +100.3% | +175.2% | $39.66B | $4.49B | 18.4% | 48.1 | |
| 12 | $182.15 | +2.35% | +128.7% | +236.7% | $39.04B | $0 | – | – | ||
| 13 | $24.06 | +3.75% | +36.39% | −14.95% | $37.37B | $449.61M | −41.9% | – | ||
| 14 | rprxRoyalty Pharma | $60.27 | −1.13% | +55.98% | +62.85% | $34.66B | $2.54B | 32.1% | 42.5 | |
| 15 | $233.48 | +0.36% | +32.67% | +63.27% | $34.50B | $9.94B | 13.8% | 25.1 | ||
| 16 | $85.98 | −0.07% | +29.55% | +29.10% | $32.45B | $4.97B | 20.1% | 32.5 | ||
| 17 | gehcGE HealthCare Technologies | $69.76 | +0.27% | −14.95% | −5.79% | $31.51B | $20.98B | 9.1% | 16.5 | |
| 18 | alnyAlnylam Pharmaceuticals | $233.29 | +0.63% | −41.33% | −51.57% | $31.22B | $3.71B | 19.7% | 42.6 | |
| 19 | roivRoivant Sciences | $34.70 | +3.49% | +59.91% | +101.0% | $25.06B | $7.53M | – | – | |
| 20 | uthrUnited Therapeutics | $543.15 | +1.88% | +11.47% | +25.34% | $23.30B | $3.15B | 41.6% | 17.8 | |
| 21 | $113.25 | +0.16% | +14.66% | +29.33% | $22.96B | $5.36B | 26.7% | 16.0 | ||
| 22 | ghGuardant Health | $157.88 | −0.45% | +54.57% | +141.2% | $21.19B | $1.18B | −38.3% | – | |
| 23 | $18.26 | −2.12% | +46.67% | +79.55% | $20.97B | $14.74B | – | – | ||
| 24 | insmInsmed | $95.29 | −1.02% | −45.25% | −42.51% | $20.81B | $1.14B | −76.9% | – | |
| 25 | $619.66 | +0.19% | +10.33% | +17.34% | $17.30B | $2.78B | 17.7% | 35.2 | ||
| 26 | $62.68 | +0.72% | +43.01% | +59.69% | $15.53B | $2.44B | 35.3% | 18.0 | ||
| 27 | $136.98 | +0.94% | −3.42% | −2.22% | $13.92B | $3.37B | 20.9% | 19.7 | ||
| 28 | $122.50 | +0.54% | +82.02% | +82.75% | $13.90B | $1.66B | 24.9% | 33.6 | ||
| 29 | $208.43 | −0.86% | +22.61% | +53.19% | $13.53B | $4.60B | 20.4% | 14.4 | ||
| 30 | $67.94 | +2.33% | −11.18% | +23.71% | $13.28B | $713.07M | – | – | ||
| 31 | smmtSummit Therapeutics | $15.57 | +6.43% | −10.98% | −25.82% | $12.42B | $0 | – | – | |
| 32 | knsaKiniksa Pharmaceuticals International | $79.48 | +1.13% | +92.68% | +105.7% | $12.40B | $754.05M | 9.7% | 169.8 | |
| 33 | btsgBrightSpring Health Services | $61.29 | +0.69% | +63.66% | +106.2% | $12.13B | $14.37B | 2.5% | 33.1 | |
| 34 | cortCorcept Therapeutics | $112.10 | +1.76% | +222.1% | +42.46% | $12.12B | $830.81M | 6.6% | 219.6 | |
| 35 | techBio-Techne | $72.49 | −0.11% | +23.26% | +17.18% | $11.37B | $1.22B | 9.0% | 103.8 | |
| 36 | $58.16 | +0.38% | −29.04% | −19.19% | $11.06B | $4.24B | 13.5% | 19.4 | ||
| 37 | algnAlign Technology | $149.00 | +1.15% | −4.58% | +14.22% | $10.58B | $4.14B | 10.0% | 25.6 | |
| 38 | $54.67 | −0.02% | −8.01% | +2.59% | $10.58B | $3.41B | 2.1% | 145.0 | ||
| 39 | mdglMadrigal Pharmaceuticals | $447.09 | −0.59% | −23.23% | +1.87% | $10.33B | $1.28B | −25.3% | – | |
| 40 | ensgEnsign | $173.05 | −2.03% | −0.66% | −4.94% | $10.09B | $5.49B | 6.9% | 26.6 | |
| 41 | rgenRepligen | $176.43 | +0.58% | +7.67% | +15.62% | $9.96B | $785.10M | 5.3% | 239.7 | |
| 42 | poddInsulet | $141.96 | +0.61% | −50.06% | −55.44% | $9.85B | $3.05B | 12.3% | 26.2 | |
| 43 | krysKrystal Biotech | $320.25 | +1.16% | +29.90% | +68.35% | $9.48B | $440.48M | 54.8% | 39.3 | |
| 44 | pcvxVaxcyte | $63.68 | +0.09% | +38.01% | +50.22% | $9.48B | – | – | – | |
| 45 | $83.97 | −2.79% | +11.10% | +33.33% | $9.36B | $13.60B | 3.0% | 23.2 | ||
| 46 | $69.89 | +0.04% | +328.5% | +490.8% | $9.11B | $616.91M | −12.2% | – | ||
| 47 | $108.07 | +3.14% | +38.89% | +80.63% | $8.99B | $105.00M | −285.3% | – | ||
| 48 | ibrxImmunityBio | $8.42 | −8.28% | +325.3% | +250.8% | $8.92B | $165.79M | −598.6% | – | |
| 49 | $139.77 | +5.29% | +340.6% | +396.3% | $8.76B | $431.80M | −31.7% | – | ||
| 50 | ptgxProtagonist Therapeutics | $134.44 | +4.42% | +53.93% | +73.47% | $8.70B | $281.99M | 29.4% | 104.9 |